These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells. Cai F; Ge I; Wang M; Biskup E; Lin X; Zhong X Tumour Biol; 2014 Apr; 35(4):3839-44. PubMed ID: 24337974 [TBL] [Abstract][Full Text] [Related]
27. Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors. Ji W; Weng X; Xu D; Cai S; Lou H; Ding L Biochem Biophys Res Commun; 2020 Jan; 522(1):121-126. PubMed ID: 31753490 [TBL] [Abstract][Full Text] [Related]
29. Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy. Ibragimova I; Cairns P Methods Mol Biol; 2011; 780():277-91. PubMed ID: 21870267 [TBL] [Abstract][Full Text] [Related]
30. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302 [TBL] [Abstract][Full Text] [Related]
31. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ. Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509 [TBL] [Abstract][Full Text] [Related]
32. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors. Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598 [TBL] [Abstract][Full Text] [Related]
33. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990 [TBL] [Abstract][Full Text] [Related]
34. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors. Christoph F; Kempkensteffen C; Weikert S; Krause H; Schostak M; Miller K; Schrader M Cancer Lett; 2007 Mar; 247(1):137-42. PubMed ID: 16697107 [TBL] [Abstract][Full Text] [Related]